Rocket Pharmaceuticals Ownership | Who Owns Rocket Pharmaceuticals?

Rocket Pharmaceuticals Ownership Summary

Rocket Pharmaceuticals is owned by 85.48% institutional investors, 3.02% insiders, and 11.50% retail investors. Rtw investments, lp is the largest institutional shareholder, holding 15.93% of RCKT shares. Vanguard Health Care Inv is the top mutual fund, with 7.11% of its assets in Rocket Pharmaceuticals shares.

RCKT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Rocket Pharmaceuticals	85.48%	3.02%	11.50%
Sector	Healthcare Stocks	488.17%	11.08%	-399.26%
Industry	Biotech Stocks	306.59%	11.10%	-217.69%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Rtw investments, lp	17.69M	15.93%	$43.34M
Maverick capital	8.36M	7.53%	$20.49M
Vanguard group	6.58M	6.99%	$82.68M
Blackrock funding, inc. /de	7.43M	6.69%	$18.20M
Blackrock	6.19M	6.61%	$133.33M
Janus henderson group	4.00M	4.25%	$50.34M
Suvretta capital management	4.14M	3.73%	$10.15M
Bioimpact capital	3.90M	3.52%	$9.56M
Price t rowe associates inc /md/	3.15M	3.34%	$39.58M
State street	2.78M	2.97%	$59.85M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
New leaf venture partners	150.71K	2.53%	$1.89M
Boxer capital	1.47M	1.66%	$31.56M
Bioimpact capital	3.90M	1.66%	$9.56M
M28 capital management lp	385.68K	1.61%	$944.92K
Privium fund management b.v.	250.98K	1.27%	$4.96M
Prosight management, lp	1.58M	0.94%	$3.87M
Newtyn management	2.00M	0.74%	$4.90M
Cowen and company	1.10M	0.65%	$23.68M
Superstring capital management lp	214.41K	0.62%	$525.31K
Rtw investments, lp	17.69M	0.62%	$43.34M

Top Buyers

Holder	Shares	% Assets	Change
Maverick capital	8.36M	0.31%	3.16M
Bioimpact capital	3.90M	1.66%	2.28M
Janus henderson group	4.00M	0.03%	2.11M
Newtyn management	2.00M	0.74%	2.00M
Qube research	1.55M	0.00%	1.35M

Top Sellers

Holder	Shares	% Assets	Change
Wellington management group llp	-	-	-12.63M
Westfield capital management co lp	-	-	-4.82M
Point72 asset management	-	-	-1.57M
State street	2.78M	0.00%	-1.41M
Pictet asset management sa	-	-	-1.32M

New Positions

Holder	Shares	% Assets	Change	Value
Newtyn management	2.00M	0.74%	2.00M	$4.90M
Monaco asset management sam	452.77K	0.19%	452.77K	$1.11M
Acadian asset management	297.90K	0.00%	297.90K	$728.00K
Voloridge investment management	274.88K	0.00%	274.88K	$673.44K
Pdt partners	265.98K	0.04%	265.98K	$651.66K

Sold Out

Holder	Change
Allspring global investments	-20.00
Smartleaf asset management	-20.00
First horizon advisors	-24.00
Evermay wealth management	-25.00
Southstate	-40.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	204	-17.07%	94,897,210	-11.80%	85	0.89%	123	-23.13%	44	2.33%
Mar 31, 2025	246	5.58%	107,782,550	-1.70%	97	0.72%	160	4.58%	43	-6.52%
Dec 31, 2024	215	8.59%	85,361,633	-7.77%	90	0.94%	140	44.33%	43	-20.37%
Sep 30, 2024	198	7.03%	92,550,219	1.43%	98	1.04%	97	-2.02%	54	10.20%
Jun 30, 2024	185	-7.04%	91,245,649	-1.15%	97	1.00%	99	11.24%	49	-23.44%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Health Care Inv	7.60M	7.11%	-
Vanguard Total Stock Mkt Idx Inv	2.71M	2.51%	-59.72K
RTW Biotech Opportunities Ord	2.40M	2.25%	-
Vanguard US Total Market Shares ETF	2.21M	2.08%	-245.50K
iShares Russell 2000 ETF	1.97M	1.83%	-37.48K
SPDR® S&P Biotech ETF	1.79M	1.66%	10.61K
Westfield Capital Mgt Co Sm-Cap Gr Eq	1.23M	1.16%	22.76K
Harbor Small Cap Growth Instl	1.23M	1.14%	-
Vanguard Small Cap Index	1.05M	0.97%	3.90K
US Small-Cap Growth II Equity Comp	993.80K	0.93%	-13.73K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Aug 27, 2025	Bjork Elisabeth	-	Buy	$34.10K
Aug 18, 2025	Militello John	See Remarks	Sell	$2.14K
Aug 19, 2025	Militello John	See Remarks	Sell	$1.08K
Aug 18, 2025	Schwartz Jonathan David	See Remarks	Sell	$5.15K
Aug 19, 2025	Schwartz Jonathan David	See Remarks	Sell	$2.41K

Insider Transactions Trends

Date	Buy	Sell
2025 Q3	1	10
2025 Q2	2	12
2025 Q1	-	6
2024 Q3	-	6
2024 Q2	-	9

RCKT Ownership FAQ

Who Owns Rocket Pharmaceuticals?

Rocket Pharmaceuticals shareholders are primarily institutional investors at 85.48%, followed by 3.02% insiders and 11.50% retail investors. The average institutional ownership in Rocket Pharmaceuticals's industry, Biotech Stocks , is 306.59%, which Rocket Pharmaceuticals falls below.

Who owns the most shares of Rocket Pharmaceuticals?

Rocket Pharmaceuticals’s largest shareholders are Rtw investments, lp (17.69M shares, 15.93%), Maverick capital (8.36M shares, 7.53%), and Vanguard group (6.58M shares, 6.99%). Together, they hold 30.45% of Rocket Pharmaceuticals’s total shares outstanding.

Does Blackrock own Rocket Pharmaceuticals?

Yes, BlackRock owns 6.61% of Rocket Pharmaceuticals, totaling 6.19M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 133.33M$. In the last quarter, BlackRock increased its holdings by 262.72K shares, a 4.43% change.

Who is Rocket Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

New leaf venture partners is Rocket Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 2.53% of its assets in 150.71K Rocket Pharmaceuticals shares, valued at 1.89M$.

Who is the top mutual fund holder of Rocket Pharmaceuticals shares?

Vanguard Health Care Inv is the top mutual fund holder of Rocket Pharmaceuticals shares, with 7.11% of its total shares outstanding invested in 7.6M Rocket Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools